CN101698664B - 医药中间体2-氨甲基吡嗪盐酸盐的制备方法 - Google Patents
医药中间体2-氨甲基吡嗪盐酸盐的制备方法 Download PDFInfo
- Publication number
- CN101698664B CN101698664B CN2009102297115A CN200910229711A CN101698664B CN 101698664 B CN101698664 B CN 101698664B CN 2009102297115 A CN2009102297115 A CN 2009102297115A CN 200910229711 A CN200910229711 A CN 200910229711A CN 101698664 B CN101698664 B CN 101698664B
- Authority
- CN
- China
- Prior art keywords
- pyrazine
- chloromethyl
- methylpyrazine
- hydrochloride
- vulkacit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 title abstract description 56
- VSCCDQDNFZXGBX-UHFFFAOYSA-N 2-methylpyrazine;hydrochloride Chemical compound Cl.CC1=CN=CC=N1 VSCCDQDNFZXGBX-UHFFFAOYSA-N 0.000 title abstract description 44
- 239000012450 pharmaceutical intermediate Substances 0.000 title abstract 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims abstract description 93
- CAWHJQAVHZEVTJ-UHFFFAOYSA-N methylpyrazine Chemical compound CC1=CN=CC=N1 CAWHJQAVHZEVTJ-UHFFFAOYSA-N 0.000 claims abstract description 76
- 238000006243 chemical reaction Methods 0.000 claims abstract description 53
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims abstract description 47
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 claims abstract description 36
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000001953 recrystallisation Methods 0.000 claims abstract description 19
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 17
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 239000011541 reaction mixture Substances 0.000 claims abstract description 16
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 229960004839 potassium iodide Drugs 0.000 claims description 30
- 235000007715 potassium iodide Nutrition 0.000 claims description 30
- FVGCPPSBZHDZPC-UHFFFAOYSA-N pyrazin-2-ylmethanamine;hydrochloride Chemical compound Cl.NCC1=CN=CC=N1 FVGCPPSBZHDZPC-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 18
- RINWGRJHXCCLOV-UHFFFAOYSA-N BPO Chemical compound BPO RINWGRJHXCCLOV-UHFFFAOYSA-N 0.000 claims description 17
- 230000035484 reaction time Effects 0.000 claims description 16
- GFHPSQFCHUIFTO-UHFFFAOYSA-N 2-(chloromethyl)pyrazine Chemical compound ClCC1=CN=CC=N1 GFHPSQFCHUIFTO-UHFFFAOYSA-N 0.000 claims description 15
- 238000013019 agitation Methods 0.000 claims description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 15
- 238000001816 cooling Methods 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 15
- 239000002994 raw material Substances 0.000 abstract description 9
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 abstract description 7
- 239000000460 chlorine Substances 0.000 abstract 3
- 229910052801 chlorine Inorganic materials 0.000 abstract 3
- 235000010299 hexamethylene tetramine Nutrition 0.000 abstract 2
- 239000004312 hexamethylene tetramine Substances 0.000 abstract 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 abstract 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 abstract 1
- 235000019400 benzoyl peroxide Nutrition 0.000 abstract 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 34
- -1 2-amine methylpyrazine class Chemical class 0.000 description 6
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 6
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- XLJMAIOERFSOGZ-UHFFFAOYSA-N cyanic acid Chemical compound OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 description 2
- PMSVVUSIPKHUMT-UHFFFAOYSA-N cyanopyrazine Chemical compound N#CC1=CN=CC=N1 PMSVVUSIPKHUMT-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 150000003216 pyrazines Chemical class 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002512 suppressor factor Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KKWVSPRXEUBOHT-UHFFFAOYSA-N CC1=CC=CC=C1.[AlH3] Chemical compound CC1=CC=CC=C1.[AlH3] KKWVSPRXEUBOHT-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 229940124056 Histamine H1 receptor antagonist Drugs 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 239000000938 histamine H1 antagonist Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102297115A CN101698664B (zh) | 2009-10-23 | 2009-10-23 | 医药中间体2-氨甲基吡嗪盐酸盐的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102297115A CN101698664B (zh) | 2009-10-23 | 2009-10-23 | 医药中间体2-氨甲基吡嗪盐酸盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101698664A CN101698664A (zh) | 2010-04-28 |
CN101698664B true CN101698664B (zh) | 2012-01-11 |
Family
ID=42147127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102297115A Expired - Fee Related CN101698664B (zh) | 2009-10-23 | 2009-10-23 | 医药中间体2-氨甲基吡嗪盐酸盐的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101698664B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104447757B (zh) * | 2014-11-17 | 2017-03-22 | 合肥华方医药科技有限公司 | 依匹斯汀的合成方法 |
CN106316966A (zh) * | 2015-06-15 | 2017-01-11 | 董运勤 | 医药中间体n-(2-吡嗪甲基)苄胺磷酸盐化合物制备方法 |
CN114890953A (zh) * | 2022-07-15 | 2022-08-12 | 济南宣正药业有限公司 | 一种2-氨甲基嘧啶盐酸盐的制备方法 |
CN116234330B (zh) * | 2023-05-10 | 2023-08-08 | 长江三峡集团实业发展(北京)有限公司 | 一种钙钛矿太阳能电池及其制备方法 |
-
2009
- 2009-10-23 CN CN2009102297115A patent/CN101698664B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101698664A (zh) | 2010-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102050687B (zh) | 一种水相体系中以氨水为氨源制备芳香伯胺的方法 | |
CN104356092A (zh) | 沃替西汀的制备方法 | |
CN101698664B (zh) | 医药中间体2-氨甲基吡嗪盐酸盐的制备方法 | |
CN109020911A (zh) | 用于制备bictegravir的中间体及其制备方法 | |
CN101153012A (zh) | 一种决奈达隆关键中间体的新的制备方法 | |
CN114315595B (zh) | 一种碳负载铁基催化剂的制备方法及其抗癌抑制剂中间体合成应用 | |
CN103694176B (zh) | 尼洛替尼中间体的制备方法 | |
CN103848777B (zh) | 一种n-(3-甲氧基丙基)-4-氨基哌啶的合成方法 | |
CN103864624A (zh) | 一种简单碱催化的n-烷基化高效制备仲胺的方法 | |
CN105566162B (zh) | 利匹韦林中间体的制备工艺 | |
CN105330598A (zh) | 一种吡非尼酮的制备方法 | |
CN106008366A (zh) | 一种利匹韦林的制备方法 | |
CN103204808B (zh) | 一种双喹啉衍生物及其制备方法和在制备抗癌药物中的应用 | |
CN103333117B (zh) | 一种4[(4-氯-2-嘧啶基)氨基]苯腈的制备方法 | |
CN101830766A (zh) | 一种氨基芳香醚化合物的合成方法 | |
CN102491953A (zh) | 一种合成氟苯尼考中间体rt0131的方法 | |
CN104876883B (zh) | 抗失眠药物苏沃雷生中间体的合成方法 | |
CN103319356A (zh) | 抗疟疾原料本芴醇一步法绿色合成工艺 | |
CN105017044A (zh) | 一种反式-4-氨甲基环己基甲酸的制备方法 | |
CN102010386B (zh) | 一种制备***美他嗪的方法 | |
CN106810452A (zh) | 一种盐酸西那卡塞的制备方法 | |
CN104341359A (zh) | 一种四甲基吡嗪的制备方法 | |
CN102603622A (zh) | 一种2-氨基-4-溴吡啶的合成方法 | |
CN107043385A (zh) | 一种制备地瑞那韦中间体的方法 | |
CN102702196A (zh) | 3-甲基-7-氮杂吲哚的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZAOZHUANG UNIVERSITY Free format text: FORMER OWNER: ZHOU FENGYAN Effective date: 20130108 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130108 Address after: 277100 Bei'an Road, Zaozhuang District, Shandong, No. 1 Patentee after: Zaozhuang University Address before: 277100 Department of chemistry and chemical engineering, Zaozhuang University, 2 Bei'an Road, Shizhong District, Zaozhuang, Shandong Patentee before: Zhou Fengyan |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120111 Termination date: 20131023 |